SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kha vu who wrote (22245)1/18/1999 1:54:00 AM
From: Street Walker  Read Replies (1) of 120523
 
LGND - treated investors badly in the past

I had traded LGND right before their last FDA
approval. When the approval was announced,
the stock dropped significantly on the
news. Traders remember these things
about a stock and shy away, imo.

If you can find other FDA pending stocks,or those
nearing critical phase III trials,
that are kind of underfollowed, with a low
flash point, they would be more interesting.
For example, check ou BIOMF, BMRA and GBFE.
I am currently not invested in any of the above
but do fit the criteria.

My next short term stock pick (under $12) is going
to be phenominal.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News